4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole, 95.0%, 25g

Estándar de viscosidad N250, ROTI®Calipure, 790 cSt (20 °C), 500 ml, envase de vidrio

Fmoc-N-(tert-butyloxycarbonylmethyl)glycine, 95%, 1g

2-Bromopropene, 97.0%, 250mg

1-(3-aminopropyl)-4-piperidinecarboxamide, 95.0%, 1g

3-(2-Bromophenyl)pentanedioic acid, 1g

4-(4-Chloroquinazolin-2-yl)morpholine, 95+%, 250mg

1-Methoxy-2-propanol>98.0%(GC)25mL

5-HYDROXY-2-(((TETRAHYDRO-2H-PYRAN-2-YL)OXY)METHYL)-4H-PYRAN-4-ONE, 95.0%, 500mg

FENOXAZOLINE, 95.0%, 100mg

(1S,4S)-tert-Butyl 3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, 95.0%, 250mg

Methyl 3-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 1g

1-ISOPROPYL-4-(TRIFLUOROMETHYL)-1H-PYRROLE-3-CARBOXYLIC ACID, 95.0%, 250mg